Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05906082 · ClinicalTrials.gov registry record · NA

Vape-Free Text-Messaging: Pilot Study

A NA study of E-cigarette Use, sponsored by Jovan Gwon, PhD, RN, FIAAN.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05906082 is a NA study of E-cigarette Use that is actively recruiting participants, run by Jovan Gwon, PhD, RN, FIAAN. The registered enrollment target is 50 participants, below the 200-participant average among 12 other E-cigarette Use trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05906082, a NA study of E-cigarette Use, is actively recruiting participants, sponsored by Jovan Gwon, PhD, RN, FIAAN.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a small pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of the e-cigarette cessation text-messaging intervention with young adults in rural areas.

Conditions Studied

Interventions

  • BEHAVIORAL E-cigarette cessation text-messaging intervention
  • BEHAVIORAL Standard care control using standard national resources

Study Locations (1)

Wisconsin

  • University of Wisconsin-Milwaukee - Milwaukee

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-05-25
Est. Completion 2026-12-31
Phase NA

Sponsor

Jovan Gwon, PhD, RN, FIAAN

1 total trials

What the Registry Record Tells You About NCT05906082

The ClinicalTrials.gov registry entry for NCT05906082 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 200-participant average among 12 other E-cigarette Use trials with a reported enrollment target (75% lower). The listed sponsor is Jovan Gwon, PhD, RN, FIAAN, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with E-cigarette Use appearing as the primary indexed condition, and to 2 interventions - of which E-cigarette cessation text-messaging intervention is the first listed.

NCT05906082 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05906082 about?

NCT05906082 is a clinical study titled "Vape-Free Text-Messaging: Pilot Study". This is a small pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of the e-cigarette cessation text-messaging intervention with young adults in rural areas.

What is the current status of trial NCT05906082?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-25. Estimated completion is 2026-12-31.

What conditions does trial NCT05906082 study?

This clinical trial studies the following conditions: E-cigarette Use.

What interventions are being tested in trial NCT05906082?

The interventions under investigation include: E-cigarette cessation text-messaging intervention (BEHAVIORAL), Standard care control using standard national resources (BEHAVIORAL).

Who is sponsoring clinical trial NCT05906082?

This trial is sponsored by Jovan Gwon, PhD, RN, FIAAN, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05906082 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for E-cigarette Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.